Stay updated on Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.

Latest updates to the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSmall editorial updates were made, including adding Melanoma and related topics (MedlinePlus Genetics) and a new revision tag (v3.4.2), while the funding notice and the previous revision tag (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check21 days agoChange DetectedA general site-wide notice about government funding and NIH status was added, along with a revision tag (Rev. 3.4.1); Melanoma-related topics and MedlinePlus Genetics were removed from related topics.SummaryDifference0.6%

- Check28 days agoChange DetectedIncludes a glossary and related topic links (Melanoma, MedlinePlus Genetics) to improve understanding and navigation of the study details. Adds minor metadata updates, including capitalization normalization of QC criteria text and a revision/version change.SummaryDifference0.4%

- Check35 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Melanoma and related-topic references (MedlinePlus Genetics), a Locations section including Virginia, and a footer revision to v3.3.3, while removing HHS Vulnerability Disclosure and Virginia Locations with an update to v3.3.2.SummaryDifference0.4%

- Check78 days agoChange DetectedRemoved the topic 'Melanoma' and the related topic 'MedlinePlus Genetics' from the study page's taxonomy/related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Helper Peptide Vaccine Plus Pembrolizumab Clinical Trial page.